It’s the ketamine episode you’ve been waiting for! Ketamine is not technically a (classic) psychedelic, yet it behaves like one. Many researchers and scientists in the psychedelic space consider it to be a psychedelic, and are applying the psychedelic assisted psychotherapy model to its use.
It’s the ketamine episode you’ve been waiting for! Ketamine is not technically a (classic) psychedelic, yet it behaves like one. Many researchers and scientists in the psychedelic space consider it to be a psychedelic, and are applying the psychedelic assisted psychotherapy model to its use.
This episode is a treasure trove of information for those who are considering ketamine for treatment, and those who want to learn more about this “chameleon” drug. Delivering this information is Dr. Kyle Greenway; a highly respected ketamine researcher and psychiatrist. He keeps a low profile, so it was truly special to have him on the show.
Dr. Greenway is a psychiatrist and assistant professor at McGill University. He completed a research fellowship at Imperial's psychedelic research centre and co-led the development of two academic clinics utilizing ketamine in treatment-resistant depression. These clinics are amongst the only services in the world to provide ketamine-assisted therapy in public healthcare systems.
Beyond his academic accolades, Dr. Greenway is very fun to learn from. I promise you that even though this conversation is highly academic, we had a lot of fun talking about serious subject matter.
Topics covered:
Show Links: